RxDoctor Payments Data

Kumari Wickramasinghe, MD

Anatomic Pathology & Clinical Pathology · San Dimas, CANPI 1043204712

Payments from drug & device makers

$143in general payments, 2019–2025

Across 8 payments — averaging $17.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$51
  • Shionogi Inc$27
  • Johnson & Johnson$25
  • Ardelyx, Inc.$15
  • Pfizer$14
  • Redhill Biopharma Inc.$11

What the payments were for

  • Food & beverage$143100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$143 in reported general payments places this provider in the 50th percentile of 814 anatomic pathology & clinical pathology providers in California.

See all anatomic pathology & clinical pathology providers in California

Medicare billing

Part B allowed, 2024
$675,225
Medicare patients
1,237
Services billed
8,729

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in San Dimas

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →